Asuragen Armored RNA Quant Zika Virus Control

Asuragen has launched its custom Armored RNA Quant Zika Virus target, which can be used to develop molecular assays. The company's Armored RNA Quant technology is the gold standard for reliable and traceable standards to develop molecular assays for virus quantitation, the company said. Developed in collaboration with Jan Felix Drexler, professor at the University of Bonn Medical Center and the German Center for Infection Research, the control is a multi-gene target designed using seven genes from the Zika Brazilian reference sequence KU321639.